Earning Analysis
Welcome to our in-depth analysis of Bruker Corp(BRKR) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of Bruker Corp earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: USD
Actual
Estimate
Surprise Analysis
| FY2025Q3 | 2025-11-03 | Pre-Market | 0.33 | 0.45 | +36.36 | 847.04M | 860.50M | +1.59 | -0.59 | +0.95 |
| FY2025Q2 | 2025-08-04 | Pre-Market | 0.33 | 0.32 | -3.03 | 810.15M | 797.40M | -1.57 | -8.62 | -17.98 |
| FY2025Q1 | 2025-05-07 | Pre-Market | 0.46 | 0.47 | +2.17 | 772.47M | 801.40M | +3.75 | +3.32 | +2.05 |
| FY2024Q4 | 2025-02-13 | Pre-Market | 0.75 | 0.76 | +1.33 | 965.61M | 979.60M | +1.45 | -0.97 | +2.46 |
| FY2024Q3 | 2024-11-05 | Pre-Market | 0.61 | 0.60 | -1.64 | 866.13M | 864.40M | -0.20 | +3.35 | -4.55 |
| FY2024Q2 | 2024-08-06 | - | 0.52 | 0.52 | - | 797.82M | 800.70M | +0.36 | -2.17 | -4.91 |
| FY2024Q1 | 2024-05-02 | - | 0.46 | 0.53 | +15.22 | 729.04M | 721.70M | -1.01 | -11.31 | -6.74 |
| FY2023Q4 | 2024-02-13 | - | 0.65 | 0.70 | +7.69 | 804.71M | 854.50M | +6.19 | +8.77 | +14.87 |
| FY2023Q3 | 2023-11-02 | - | 0.63 | 0.74 | +17.46 | 715.94M | 742.80M | +3.75 | -1.05 | +1.25 |
| FY2023Q2 | 2023-08-03 | - | 0.48 | 0.50 | +4.17 | 648.05M | 681.90M | +5.22 | -4.83 | -7.43 |
BRKR Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, Bruker Corp reported performance for FY2025Q3, announced on 2025-11-03. The company achieved an EPS of 0.45, compared to analyst estimates of 0.33 by 36.36% . Revenue for the quarter reached 860.50M compared to expectations of 847.04M by 1.59% .
The stock price reacted with a -0.59% one-day change and a 0.95% five-day change following the earnings release. These movements reflect market reaction in Bruker Corp growth trajectory and strategic initiatives.
BRKR Earnings Forecast
Looking ahead, Bruker Corp(BRKR) remains a focal point for investors seeking growth opportunities. Analyst forecasts for 2025/Q4 project quarter revenue of 958.80M and an EPS of 0.65.
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for FY2025 have been Revise Downward by -0.92%, while EPS estimates have been Revise Downward by -4.88%. For the upcoming Q4 2025, revenue estimates have been adjusted Revise Downward by -4.21% . These revisions correlate with a 56.93% change in stock price over the same period, suggesting potential buying opportunities for investors who believe in Bruker Corp long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between BRKR's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Revenue Estimates for FY2025
Revise Downward
-0.92%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-4.88%
In Past 3 Month
Revenue Estimates for Q4 2025
Revise Downward
-4.21%
In Past 3 Month
Stock Price
Go Up
+56.93%
In Past 3 Month
1Y
3Y
5Y
Annual FY 2025
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-Annual FY 2025:3.42B
--
EPS Estimate-Annual FY 2025:1.88
—
Stock Price48.38
BRKR Revenue and EPS Performance: A Historical Perspective
Bruker Corp revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
FY2025Q3 (2025-11-03,Pre-Market):
EPS: 0.45 (Actual) vs.0.33 (Estimate) (36.36%)
Revenue: 860.50M (Actual) vs. 847.04M (Estimate) (1.59%)
Price Reaction: -0.59%(1-Day), 0.95%(5-Day)
FY2025Q2 (2025-08-04,Pre-Market):
EPS: 0.32 (Actual) vs.0.33 (Estimate) (-3.03%)
Revenue: 797.40M (Actual) vs. 810.15M (Estimate) (-1.57%)
Price Reaction: -8.62%(1-Day), -17.98%(5-Day)
FY2025Q1 (2025-05-07,Pre-Market):
EPS: 0.47 (Actual) vs.0.46 (Estimate) (2.17%)
Revenue: 801.40M (Actual) vs. 772.47M (Estimate) (3.75%)
Price Reaction: 3.32%(1-Day), 2.05%(5-Day)
Earnings Reaction
The chart below shows how BRKR performed 10 days before and after its earnings report, based on data from the past quarters. Typically, BRKR sees a +2.96% change in stock price 10 days leading up to the earnings, and a -0.57% change 10 days following the report. On the earnings day itself, the stock moves by -1.41%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in SEP/2025, the stock changed 4.31% on the day following the earnings release and then changed by 7.90% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
Bruker Corp (BRKR) Q3 2025 Earnings Call Summary
Negative
2025-11-03
The earnings call summary indicates declining revenue, margins, and EPS for 2025, with weak financial performance and cautious guidance. The Q&A reveals management's uncertainty and lack of clarity on key issues, including future revenue growth and the impact of external factors like the government shutdown. Despite some positive expectations for 2026, such as margin expansion and cost savings, the current negative trends and lack of clear guidance suggest a negative market reaction in the short term.
Bruker Corp (BRKR) Q2 2025 Earnings Call Summary
Negative
2025-08-04
The earnings call reveals several negative factors: declining revenues in key segments, reduced operating cash flow, and muted growth outlook due to market challenges. Despite some confidence in Q4 ramp-up and cost-saving measures, the lack of clarity in management responses, especially regarding fiscal '26 growth and acquisition impacts, adds uncertainty. The negative sentiment is compounded by anticipated declines in U.S. academic funding and tariff headwinds. Overall, these elements suggest a likely negative stock price movement in the short term.
Bruker Corp (BRKR) Q1 2025 Earnings Call Summary
Negative
2025-05-07
The earnings call highlights several concerns: supply chain challenges, tariff impacts, and foreign exchange headwinds affecting margins and EPS. The Q&A session reveals uncertainties around U.S. policy changes, potential delays in China, and weak academic market orders. Despite revenue growth, the lack of a shareholder return plan and declining margins contribute to a negative sentiment. The management's unclear responses further exacerbate concerns, leading to a negative prediction for the stock price over the next two weeks.
Bruker Corporation (BRKR) Q3 2024 Earnings Call Summary
Negative
2024-11-05
The earnings call revealed several concerning factors: margin dilution, declining cash flow, and weak guidance due to economic factors and acquisition challenges. Despite revenue growth, the market's reaction is likely negative due to missed EPS expectations, lower guidance, and lack of share repurchase plans. The Q&A section highlighted significant uncertainties, especially regarding China and biopharma demand, further dampening sentiment. These factors point to a negative stock price movement over the next two weeks, likely falling between -2% to -8%.
People Also Watch
FAQ
What were the key highlights of BRKR’s latest earnings report for FY2025Q3?
How did BRKR’s stock price react after the FY2025Q3 earnings release?
What are the revenue and EPS estimates for BRKR for 2025/Q4?
How does BRKR’s stock price correlate with earnings forecast revisions?
What should investors expect from BRKR’s next earnings report?